Abstract
Limited potential treatment options are available for the management of severe symptomatic asthma. Bronchial Thermoplasty is considered as a new treatment modality for adult patients with severe refractory asthma despite being on conventional pharmacotherapy. We will discuss the evidence for and against Bronchial Thermoplasty in the management of severe refractory asthma.
Keywords: Bronchial thermoplasty, severe asthma, airway smooth muscles.
Current Respiratory Medicine Reviews
Title:Bronchial Thermoplasty: Burn to Cure?
Volume: 10 Issue: 1
Author(s): Chinthaka P. Bulathsinghala and Daniel A. Gerardi
Affiliation:
Keywords: Bronchial thermoplasty, severe asthma, airway smooth muscles.
Abstract: Limited potential treatment options are available for the management of severe symptomatic asthma. Bronchial Thermoplasty is considered as a new treatment modality for adult patients with severe refractory asthma despite being on conventional pharmacotherapy. We will discuss the evidence for and against Bronchial Thermoplasty in the management of severe refractory asthma.
Export Options
About this article
Cite this article as:
Bulathsinghala P. Chinthaka and Gerardi A. Daniel, Bronchial Thermoplasty: Burn to Cure?, Current Respiratory Medicine Reviews 2014; 10 (1) . https://dx.doi.org/10.2174/1573398X1001140811153732
DOI https://dx.doi.org/10.2174/1573398X1001140811153732 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa
Current Pharmaceutical Design Noscapine and its Analogs as Chemotherapeutic Agent: Current updates
Current Topics in Medicinal Chemistry Silver and Other Metals in the Treatment of Gastrointestinal Diseases
Current Medicinal Chemistry Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Current Genomics Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Current Medicinal Chemistry COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Enkephalinase Inhibitors: Potential Agents for the Management of Pain
Current Drug Targets Advancement in Nanoparticle-based Biosensors for Point-of-care <i>In vitro</i> Diagnostics
Current Topics in Medicinal Chemistry Production of nanosuspensions as a tool to improve drug bioavailability: focus on topical delivery
Current Pharmaceutical Design Aerosol Drug Administration with Helium-Oxygen (Heliox) Mixtures: An Overview
Current Respiratory Medicine Reviews Inhaled Corticosteroids in COPD: Pros and Cons
Current Drug Targets Vitamin D and the Adaptive Immune System with Special Emphasis to Allergic Reactions and Allograft Rejection
Inflammation & Allergy - Drug Targets (Discontinued) Glucocorticoid Receptors and Bone
Current Pharmaceutical Design Systems Biology Research into Cardiovascular Disease: Contributions of Lipidomics-based Approaches to Biomarker Discovery
Current Drug Discovery Technologies Editorial [Hot Topic Advantages and Disadvantages of Inhaled Corticosteroids in the Treatment of Pulmonary Diseases Guest Editor: Nazan Cobanoglu]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Effects of Ranolazine on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery The Role of Adenosine in Rheumatoid Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Antimicrobial Evaluation of Erythrinan Alkaloids from Erythrina cristagalli L.
Medicinal Chemistry Weka Machine Learning for Predicting the Phospholipidosis Inducing Potential
Current Topics in Medicinal Chemistry New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs
Current Neuropharmacology